Edgen Stock·Nov 19 2025, 06:17返回
返回
艾伯維獲得FDA完全批准EPKINLY聯合療法治療濾泡性淋巴瘤
Edgen Stock·Nov 19 2025, 06:17
[1] 艾伯維宣布美國FDA批准EPKINLY® (epcoritamab ... (https://news.abbvie.com/2025-11-18-AbbVie-Ann ...)[2] FDA批准epcoritamab-bysp用於濾泡性淋巴瘤適應症 (https://www.fda.gov/drugs/resources-informati ...)[3] Epcoritamab聯合利妥昔單抗和來那度胺達到兩項主要終點... (https://www.onclive.com/view/epcoritamab-plus ...)